脑梗死与脑出血早期鉴别的血清标志物概述

doi:10.3969/j.issn.1673-5765.2019.04.019

摘要/Abstract

摘要：

脑梗死是因局部脑组织血液供应障碍而导致脑组织坏死；脑出血则是因为各种原因导致脑实质内血管破裂出血。虽然二者发病时临床症状有一定相似性，但其发病机制及病理生理过程截然不同，这种差异可能会导致发病早期血清中一些蛋白及基因表达的差异。目前，文献中报道了几种可用于鉴别脑梗死及脑出血的血清标志物，并分析了这些标志物用于脑梗死及脑出血早期鉴别诊断的价值。本文将对这些血清标志物进行综述，希望能够为卒中早期鉴别诊断提供新思路。

文章导读： 血清中存在早期鉴别脑出血与脑梗死的标志物，不同标志物的组合可提高鉴别诊断准确率。

关键词: 脑梗死; 脑出血; 生物标志物; 鉴别诊断

Abstract:

Cerebral infarction is caused by cerebrovascular stenosis or occlusion, while intracerebral hemorrhage is caused by cerebrovascular rupture. Although the two kinds of stroke present similar symptoms, their pathogenesis are different, which could lead to different expressions of some proteins and genes at the acute phase of stroke. Recently, some literature reported several serum biomarkers which could differentiate cerebral infarction and cerebral hemorrhage and the early diagnostic value of these biomarkers. This article reviewed the progress of serum biomarkers which could differentiate cerebral infarction and cerebral hemorrhage at the early stage, to provide a reference for early differential diagnosis of stroke.

Key words: Cerebral infarction; Intracerebral hemorrhage; Biomarker; Differential diagnosis

张熙，苏俊辉，靳令经，滕飞. 脑梗死与脑出血早期鉴别的血清标志物概述[J]. 中国卒中杂志, 2019, 14(04): 389-394.

ZHANG Xi, SU Jun-Hui, JIN Ling-Jing, TENG Fei. Advance in Serum Biomarkers for Early Identification of Cerebral Infarction and Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2019, 14(04): 389-394.

参考文献

[1] LLOYD-JONES D，ADAMS R，CARNETHON M，

et al. Heart disease and stroke statistics-2009 update：

a report from the American Heart Association

Statistics Committee and Stroke Statistics

Subcommittee[J]. Circulation，2009，119（3）：480-

486.

[2] 伞勇智，李峰，杨鸣，等. 凝血机制新进展及脑梗死

抗凝治疗的展望[J]. 中华脑血管病杂志（电子版），

2012，6（2）：35-40.

[3] 官念，吴碧华，刘黎明，等. 脑出血病因及相关机制

的研究进展[J]. 中华老年心脑血管病杂志，2016，18

（6）：670-672.

[4] ENG L F，GHIRNIKAR R S，LEE Y L. Glial

fibrillary acidic protein：GFAP-thirty-one years （1969-2000）[J]. Neurochem Res，2000，25（9-10）：

1439-1451.

[5] DVORAK F，HABERER I，SITZER M，et al.

Characterisation of the diagnostic window of serum

glial fibrillary acidic protein for the differentiation of

intracerebral haemorrhage and ischaemic stroke[J].

Cerebrovasc Dis，2009，27（1）：37-41.

[6] UNDÉN J，STRANDBERG K，MALMJ，et al.

Explorative investigation of biomarkers of brain

damage and coagulation system activation in clinical

stroke differentiation[J]. J Neurol，2009，256（1）：

72-77.

[7] HERRMANN M，VOS P，WUNDERLICHMT，et

al. Release of glial tissue-specific proteins after

acute stroke：a comparative analysis of serum

concentrations of protein S-100B and glial fibrillary

acidic protein[J]. Stroke，2000，31（11）：2670-2677.

[8] BRUNKHORST R，PFEILSCHIFTER W，FOERCH

C. Astroglial proteins as diagnostic markers of

acute intracerebral hemorrhage-pathophysiological

background and clinical findings[J]. Transl Stroke

Res，2010，1（4）：246-251.

[9] PERSSON L，HÅRDEMARK H G，BOLANDER

H G，et al. Neurologic and neuropathologic outcome

after middle cerebral artery occlusion in rats[J].

Stroke，1989，20（5）：641-645.

[10] WUNDERLICH M T，WALLESCH C W，

GOERTLER M. Release of glial fibrillary acidic

protein is related to the neurovascular status in acute

ischemic stroke[J]. Eur J Neurol，2006，13（10）：

1118-1123.

[11] FOERCH C，CURDT I，YAN B，et al. Serum

glial fibrillary acidic protein as a biomarker for

intracerebral haemorrhage in patients with acute

stroke[J]. J Neurol Neurosurg Psychiatry，2006，77

（2）：181-184.

[12] FOERCH C，NIESSNER M，BACK T，et al.

Diagnostic accuracy of plasma glial fibrillary acidic

protein for differentiating intracerebral hemorrhage

and cerebral ischemia in patients with symptoms of

acute stroke[J]. Clin Chem，2012，58（1）：237-245.

[13] REN C，KOBEISSY F，ALAWIEH A，et al.

Assessment of serum UCH-L1 and GFAP in acute

stroke patients[J/OL]. Sci Rep，2016，6：24588. https：

//doi.org/10.1038/srep24588.

[14] BARGER S W，VAN ELDIK L J. S100 beta

stimulates calcium fluxes in glial and neuronal

cells[J]. J Biol Chem，1992，267（14）：9689-9694.

[15] KANNER A A，MARCHI N，FAZIO V，et al.

Serum S100beta：a noninvasive marker of bloodbrain

barrier function and brain lesions[J]. Cancer，

2003，97（11）：2806-2813.

[16] BUTTNER T，WEYERS S，POSTERT T，et al.

S-100 protein：serum marker of focal brain damage

after ischemic territorial MCA infarction[J]. Stroke，

1997，28（10）：1961-1965.

[17] DELGADO P，ALVAREZ SABIN J，

SANTAMARINA E，et al. Plasma S100B level

after acute spontaneous intracerebral hemorrhage[J].

Stroke，2006，37（11）：2837-2839.

[18] ZHOU S，BAO J，WANG Y，et al. S100β as a

biomarker for differential diagnosis of intracerebral

hemorrhage and ischemic stroke[J]. Neurol Res，

2016，38（4）：327-332.

[19] GINGRICH M B，TRAYNELIS S F. Serine

proteases and brain damage - is there a link?[J].

Trends Neurosci，2000，23（9）：399-407.

[20] DAMBINOVA S A，KHOUNTEEV G A，

SKOROMETS A A. Multiple panel of biomarkers

for TIA/stroke evaluation[J]. Stroke，2002，33（5）：

1181-1182.

[21] DAMBINOVA S A，KHOUNTEEV G A，

IZYKENOVA G A，et al. Blood test detecting

autoantibodies to N-methyl-D-aspartate

neuroreceptors for evaluation of patients with

transient ischemic attack and stroke[J]. Clin Chem，

2003，49（10）：1752-1762.

[22] WILKINSON K D. Regulation of ubiquitindependent

processes by deubiquitinating enzymes[J].

FASEB J，1997，11（14）：1245-1256.

[23] LIU M C，AKINYI L，SCHARF D，et al. Ubiquitin

C-terminal hydrolase-L1 as a biomarker for ischemic

and traumatic brain injury in rats[J]. Eur J Neurosci，

2010，31（4）：722-732.

[24] REN C，ZOLTEWICZ S，GUINGAB-CAGMATJ，

et al. Different expression of ubiquitin C-terminal

hydrolase-L1 and alphaII-spectrin in ischemic

and hemorrhagic stroke：Potential biomarkers in

diagnosis[J/OL]. Brain Res，2013，1540：84-91. https：

//doi.org/10.1016/j.brainres.2013.09.051.

[25] KORFIAS S，STRANJALIS G，PAPADIMITRIOU

A，et al. Serum S-100B protein as a biochemical

marker of brain injury：a review of current

concepts[J]. Curr Med Chem，2006，13（30）：3719-

3731.

[26] ROSSO C，ROSENBAUM D，PIRESC，et al.

Lipoprotein-associated phospholipase A2 during

the hyperacute stage of ischemic and hemorrhagic

strokes[J/OL]. J Stroke Cerebrovasc Dis，2014，23

（4）：e277-e282. https：//doi.org/10.1016/j.jstrokecere

brovasdis.2013.11.024.

[27] SHEARER K D，STONEY P N，MORGAN P J，et al. A vitamin for the brain[J]. Trends Neurosci，2012，

35（12）：733-741.

[28] PLANE J M，WHITNEY J T，SCHALLERT T，et

al. Retinoic acid and environmental enrichment alter

subventricular zone and striatal neurogenesis after

stroke[J]. Exp Neurol. 2008，214（1）：125-134.

[29] CHOI B K，KIM J H，JUNG J S，et al. Reduction

of ischemia-induced cerebral injury by all-transretinoic

acid[J]. Exp Brain Res，2009，193（4）：581-

589.

[30] HARVEY B K，SHEN H，CHEN G J，et al. Midkine

and retinoic acid reduce cerebral infarction induced

by middle cerebral artery ligation in rats[J]. Neurosci

Lett，2004，369（2）：138-141.

[31] XIAO Y，XU A，HUI X，et al. Circulating

lipocalin-2 and retinol-binding protein 4 are

associated with intima-media thickness and

subclinical atherosclerosis in patients with type 2

diabetes[J/OL]. PloS one，2013，8（6）：e66607. https：

//doi.org/10.1371/journal.pone.0066607.

[32] KADOGLOU N P，LAMBADIARI V，

GASTOUNIOTI A，et al. The relationship of novel

adipokines，RBP4 and omentin-1，with carotid

atherosclerosis severity and vulnerability[J].

Atherosclerosis，2014，235（2）：606-612.

[33] LLOMBART V，GARCIA-BERROCOSO

T，BUSTAMANTE A，et al. Plasmatic retinolbinding

protein 4 and glial fibrillary acidic protein

as biomarkers to differentiate ischemic stroke and

intracerebral hemorrhage[J]. J Neurochem，2016，136

（2）：416-424.

[34] YAN S F，NAKA Y，HUDSON B I，et al. The

ligand/RAGE axis：lighting the fuse and igniting

vascular stress[J]. Curr Atheroscler Rep，2006，8（3）：

232-239.

[35] CHANG J S，WENDT T，QU W，et al. Oxygen

deprivation triggers upregulation of early growth

response-1 by the receptor for advanced glycation

end products[J]. Circ Res，2008，102（8）：905-913.

[36] DONATO R. RAGE：a single receptor for several

ligands and different cellular responses：the case of

certain S100 proteins[J]. Curr Mol Med，2007，7（8）：

711-724.

[37] PARK I H，YEON S I，YOUN J H，et al. Expression

of a novel secreted splice variant of the receptor for

advanced glycation end products（RAGE）in human

brain astrocytes and peripheral blood mononuclear

cells[J]. Mol Immunol，2004，40（16）：1203-1211.

[38] MONTANER J，MENDIOROZ M，DELGADO

P，et al. Differentiating ischemic from hemorrhagic

stroke using plasma biomarkers：the S100B/RAGE

pathway[J]. J Proteomics，2012，75（15）：4758-4765.

[39] WALLDIUS G，JUNGNER I. Apolipoprotein A-I

versus HDL cholesterol in the prediction of risk

for myocardial infarction and stroke[J]. Curr Opin

Cardiol，2007，22（4）：359-367.

[40] WALLDIUS G，AASTVEIT A H，JUNGNER I.

Stroke mortality and the apoB/apoA-I ratio：results

of the AMORIS prospective study[J]. J Intern Med，

2006，259（3）：259-266.

[41] BARTER P J，NICHOLLS S，RYE K A，et al.

Antiinflammatory properties of HDL[J]. Circ Res，

2004，95（8）：764-772.

[42] MOVVA R，RADER D J. Laboratory assessment

of HDL heterogeneity and function[J]. Clin Chem，

2008，54（5）：788-800.

[43] WALSH K B，HART K，ROLL S，et al.

Apolipoprotein A-I and Paraoxonase-1 Are Potential

Blood Biomarkers for Ischemic Stroke Diagnosis[J].

J Stroke Cerebrovasc Dis，2016，25（6）：1360-1365.

[44] DYKSTRA-AIELLO C，JICKLING G C，ANDER

B P，et al. Intracerebral hemorrhage and ischemic

stroke of different etiologies have distinct

alternatively spliced mRNA profiles in the blood：a

pilot RNA-seq study[J]. Transl Stroke Res，2015，6

（4）：284-289.

（